| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 04/02/2008 | CN100378074C 2-,3-4- or 5-substituted-n1-(benzensulfonyl)indoles and their use in therapy |
| 04/01/2008 | US7351841 Heterocyclic compounds and thrombopoietin receptor activators |
| 04/01/2008 | US7351825 4-[5-((1S,2R)-1-Carboxy-2-phenyl-cyclopropylsulfamoyl)-thiophen-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester; aggrecanase and matrix metalloproteinase (with zinc in the catalytic active center) (MMP) inhibitor; antiarthritic agent: osteoarthritis, rheumatoid arthritis |
| 04/01/2008 | US7351823 5-Chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophenecarboxamide formed by reacting 4-{4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl}-morpholin-3-one hydrochloride with 5-chlorothiophene-2-carbonyl chloride |
| 04/01/2008 | US7351822 Serine protease inhibitors |
| 04/01/2008 | US7351735 (3-Amino-6-phenyl-benzofuran-2-yl)-(2,4-dichloro-phenyl)-methanone; antiprolifrative, anticarcinogenic, antitumor agent; lymphomas, sarcomas, and leukemias |
| 04/01/2008 | US7351721 Amino acid derivatives and pharmaceutical composition comprising, as active ingredients, them |
| 04/01/2008 | US7351712 Inhibitors of the FAK (focal adhesion kinase) protein tyrosine kinases, antiproliferative, antitumor; for example 5-{4-[(1-Hydroxy-cyclopentylmethyl)-amino]-5-trifluoromethyl-pyrimidin-2-ylamino}-1,3-dihydro-indol-2-one |
| 04/01/2008 | US7351703 Which modulate the endogenous production of cyclic guanosine monophosphate (cGMP); for therapy and prophylaxis of cardiovascular disorders such as high blood pressure, angina pectoris, cardiac insufficency, thromboses, and/or atherosclerosis |
| 04/01/2008 | US7351402 Placing sample of polarizing agent comprises two nitroxide radicals tethered by a polyethylene glycol chain within a magnetic field; irradiating the sample with radiation that causes a mutual electron spin flip of the at least two unpaired electrons in combination with a nuclear spin flip o |
| 04/01/2008 | CA2432578C Quinazolone derivatives as alpha 1a/b adrenergic receptor antagonists |
| 04/01/2008 | CA2145661C Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating hiv and other retroviruses |
| 03/27/2008 | WO2008035737A1 4-nitrobenzoyl derivative having sulfoxyimino group and herbicide for rice plant |
| 03/27/2008 | WO2008035726A1 Pyridine derivative substituted by heteroaryl ring, and antifungal agent comprising the same |
| 03/27/2008 | WO2008034863A2 Sulfonylpyrazoline carboxamidine derivatives as 5-ht6 antagonists |
| 03/27/2008 | WO2008011560A3 Benzothiophene inhibitors of rho kinase |
| 03/27/2008 | WO2008009405A3 Novel pyridazine derivatives |
| 03/27/2008 | WO2008008660A3 Cyclopentane derivatives as antiglaucoma agents |
| 03/27/2008 | WO2008008431A3 Heteroaryl sulfonamides and ccr2/ccr9 |
| 03/27/2008 | WO2008002671A3 Metalloprotease inhibitors |
| 03/27/2008 | WO2007136668A9 N-benzoyl-and n-benzylpyrrolidin-3-ylamines as histamine-3 antagonists |
| 03/27/2008 | WO2007109334B1 Sip receptor modulating compounds and use thereof |
| 03/27/2008 | WO2007094513A3 Cyclic amine compound and use thereof for the prophylaxis or treatment of hypertension |
| 03/27/2008 | WO2006125621A8 Substituted piperidines as renin inhibitors |
| 03/27/2008 | US20080076817 Neurotrophic N-glyoxyl-prolyl ester compounds e.g. 3-phenyl-1-propyl (2S)-1-(3,3-dimethyl-1,2-dioxopentyl)-2-pyrrolidinecarboxylate; non-immunosuppressive; side effect reduction; neurodegenerative diseases |
| 03/27/2008 | US20080076795 1H-benzo[F]indazol-5-YL derivatives as selective glucocorticoid receptor modulators |
| 03/27/2008 | DE102006042143A1 Neue substituierte Bipyridin-Derivate und ihre Verwendung New substituted bipyridine derivatives and their use |
| 03/27/2008 | CA2664411A1 Platelet adp receptor inhibitors |
| 03/27/2008 | CA2662838A1 Oxindole derivatives |
| 03/27/2008 | CA2662484A1 Sulfonylpyrazole and sulfonylpyrazoline carboxamidine derivatives as 5-ht6 antagonists |
| 03/26/2008 | EP1903038A1 N-(1-hetaryl-piperidin-4-yl)-(het)arylamide as EP2 receptor modulators |
| 03/26/2008 | EP1902046A1 Piperidine derivatives useful as histamine h3 antagonists |
| 03/26/2008 | EP1902039A1 6-oxazol-4-ylmethoxy-alkoxymethyl substituted benzoic acid derivatives forming ppar ligands, methods for production and the use thereof in the form of drugs |
| 03/26/2008 | EP1902026A2 Tetrahydrocarbazole derivatives useful as androgen receptor modulators (sarm) |
| 03/26/2008 | EP1902025A1 Kinase inhibitors |
| 03/26/2008 | EP1740592A4 Methyl 2,4,9-trithiaadamantane-7-carboxylate |
| 03/26/2008 | CN101151261A Pyrimidine compounds having tie2 (TEK) inhibitory activity |
| 03/26/2008 | CN101151253A Substituted n-[pyrimidin-2-ylmethyl]carboxamides and their use as herbicides and plant growth regulators |
| 03/26/2008 | CN101151251A Substituted pyrazolyl oxyphenyl derivatives used as herbicides |
| 03/26/2008 | CN101148447A Method for preparing Sertaconazole Nitrate by using polyglycol-400 as catalyst |
| 03/26/2008 | CN100376569C Inhibitors of farnesyl protein transferase |
| 03/26/2008 | CN100376564C Substituted heterocyclic benzoeycloalkenes and the use thereof as substances having analgesic effect |
| 03/26/2008 | CN100376557C Quinoline derivatives as ligands for the neuropeptide y receptor |
| 03/25/2008 | US7348440 Mitotic kinesin inhibitors |
| 03/25/2008 | US7348433 3-[p-(phenoxy, phenylthio, phenylsulfinyl, or phenylsulfonyl)benzyl]-quinolin-2(1H)-ones or 5--[p-(phenoxy, phenylthio, phenylsulfinyl, or phenylsulfonyl)benzyl]-pyrrolo[3,2,1-IJ]quinolin-4(4H)-ones; type E antagonists; analgesics, antipyretics, antiinflammatory agents; side effect reduction |
| 03/25/2008 | US7348428 Triarylamine containing monomers for optoelectronic devices |
| 03/25/2008 | US7348427 Substituted with an amido heterocylic groups; infection by Gram-positive bacteria. |
| 03/25/2008 | US7348425 Inhibitors of HCV replication |
| 03/25/2008 | US7348357 bactericide; derivatives of pseudopeptide Andrimid in which beta-phenylalanine amide is replaced by heteroaromatic or substituted aromatic amide; N-{(1S)-3-[((1S)-1-{[(3R,4S)-1,4-Dimethyl-2,5-dioxo-3-pyrrolidinyl]carbonyl}-2-methylpropyl)amino]-3-oxo-1-phenylpropyl}-2-pyridinecarboxamide; antibiotics |
| 03/25/2008 | US7348355 Treating obesity with the Microsomal triglyceride transfer protein inhibitor (S) N-{2-[benzyl(methyl)amino]-2-oxo-1-phenylethyl}-1-methyl-5-[4'-(trifluoromethyl)[1,1'-biphenyl]-2-carboxamido]-1H-indole-2-carboxamide and another lipid lowering agent such as a statin or fibrate |
| 03/25/2008 | US7348351 for treating conditions resulting from fibrinolytic disorders such as deep vein thrombosis and coronary heart disease, and pulmonary fibrosis |
| 03/25/2008 | US7348346 Use as antidiabetic agents, treating hyperglycemia, syndrome X, hyperinsulinemia, obesity, atherosclerosis; (3S, 5S)-4-([5-(Thiazolidine-3-carbonyl)-pyrrolidin-3-ylmethyl]-sulfamoyl)-benzoic acid for example |
| 03/25/2008 | US7348342 5-(4-Fluorophenyl)-1-(4-methylsulfoximinylphenyl)-3-trifluoromethyl-1H-pyrazole; prostaglandin and cyclooxygenase inhibitor; antiinflammatory, analgesic, and antipyretic agent |
| 03/25/2008 | US7348341 Chemical compounds |
| 03/25/2008 | US7348338 PPAR active compounds |
| 03/25/2008 | US7348328 MCH antagonists for the treatment of obesity |
| 03/25/2008 | US7348326 in brain; (2,5-difluorodifluorophenyl)-N-methyl-N-((1-propylbenzimidazol-2-yl)methyl)carboxamide; anxiolitic and antidepressant; finding and altering the signal-transducing activity of gamma aminobutyric acid (GABA) receptors; detectably-labeled antagonist/agonist of GABAR |
| 03/25/2008 | US7348324 Cyclic amine compounds as CCR5 antagonists |
| 03/25/2008 | CA2416867C Cyclopentanoindoles, compositions containing such compounds and methods of treatment |
| 03/25/2008 | CA2268709C Hiv protease inhibitors |
| 03/25/2008 | CA2268394C New heterocyclylmethyl-substituted pyrazol derivates |
| 03/25/2008 | CA2250002C Cephem compounds and drugs containing the compounds |
| 03/20/2008 | WO2008033854A1 Certain substituted amides, method of making, and method of use thereof |
| 03/20/2008 | WO2008033834A1 Pyrimidines derivatives and their use as kinase inhibitors |
| 03/20/2008 | WO2008015189A3 Fungicidal n-cycloalkyl-carboxamide derivatives |
| 03/20/2008 | WO2008012470A3 Substituted imidazolone derivatives, preparation and uses |
| 03/20/2008 | WO2007140174A3 Compounds and methods for modulating fxr |
| 03/20/2008 | WO2007113327A3 Fungicide n-cyclopropyl-sulfonylamide derivatives |
| 03/20/2008 | WO2007080131A3 Anthranilamide derivatives and their use for the control of insects and acari |
| 03/20/2008 | WO2007020098A8 Method for producing substituted pyrazoles |
| 03/20/2008 | WO2006094187A3 Phthalazine, aza- and diaza-phthalazine compounds and methods of use |
| 03/20/2008 | US20080070951 Viricides; HIV antivirals effective against problematic drug escape mutants; N-[(1S,1aR,7bR)-4,7-difluoro-1,1a,2,7b-tetrahydrocyclopropa[c]chromen-1-yl]-N'-[5-(4-(sulfonamido)phenoxy)-2-pyridinyl]urea |
| 03/20/2008 | US20080070947 Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis |
| 03/20/2008 | US20080070945 4-(2-methyl-5,6,7,8-tetrahydro-quinolin-7-ylmethyl)-1,3-dihydro-imidazole-2-thione as specific alpha2b agonist and methods of using the same |
| 03/20/2008 | US20080070916 Treating disorders such as proliferative diseases, and cancer; compounds can act as probes of biological function; libraries; for example, 2-ethoxy-3-(2-hydroxyethoxyethoxyethyl)-4-(1-acetylindol-3-yl)-6-(morpholinocarbonyl)-2H-3,4-dihydropyran |
| 03/20/2008 | US20080070906 Quinolinone derivatives |
| 03/20/2008 | US20080070903 New pyrimidine derivatives and new pyridine derivatives |
| 03/20/2008 | US20080070902 Cinnamide Compound |
| 03/20/2008 | US20080070864 Modulating the activity of farnesoid X receptor (FXR) and/or orphan nuclear receptors; N-[3-(2,4-dimethylphenyl)-4-oxo-3,4-dihydroquinazolin-2-ylmethyl]benzenesulfonamide |
| 03/20/2008 | DE102007037830A1 Indolinsulfonamidverbindungen Indolinsulfonamidverbindungen |
| 03/20/2008 | CA2663189A1 Benzimidazolone derivatives |
| 03/20/2008 | CA2661938A1 Pyrimidines derivatives and their use as kinase inhibitors |
| 03/20/2008 | CA2661654A1 Certain substituted amides, method of making, and method of use thereof |
| 03/19/2008 | EP1900732A1 Novel nitrogenated heterocyclic compound and salt thereof |
| 03/19/2008 | EP1900727A1 Aminopyridine derivatives as kinase inhibitors |
| 03/19/2008 | EP1899330A1 Substituted glycinamides having an antithrombotic and factor xa-inhibiting effect |
| 03/19/2008 | EP1899329A1 Pyrimidine-substituted benzimidazole derivatives as protein kinase inhibitors |
| 03/19/2008 | EP1899324A2 Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists |
| 03/19/2008 | EP1899322A1 Isoquinoline derivatives as inhibitors of rho-kinase |
| 03/19/2008 | EP1899320A1 SUBSTITUTED PYRR0LIDIN-2-0NES , PIPERIDIN-2-0NES AND ISOTHIAZOLIDINE-1, 1-DIOXIDES, THEIR USE AS KVl .5 POTASSIUM CHANNEL BLOCKERS AND PHARMACEUTICAL PREPARATIONS COMPRISING THEM |
| 03/19/2008 | EP1899299A2 C-linked cyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 03/19/2008 | EP1899296A1 Histamine-3 receptor antagonists |
| 03/19/2008 | EP1898905A2 Hydroisoindoline tachykinin receptor antagonists |
| 03/19/2008 | EP1646613B1 Quinoline and quinazoline derivatives having affinity for 5ht1-type receptors |
| 03/19/2008 | EP1562933B1 Substituted amine derivatives and methods of use in the treatment of angiogenesis related disorders |
| 03/19/2008 | EP1499316B1 (1-4-piperidinyl)benzimidazole derivatives useful as histamine h3 antagonists |
| 03/19/2008 | EP1458380B1 Cis-2,4,5- triphenyl-imidazolines and their use in the treatment of tumors |
| 03/19/2008 | EP1042293B1 Substituted pyridine and pyridazine compounds and their pharmaceutical use |
| 03/19/2008 | CN101146800A Organic compounds useful for the treatment of alzheimer's disease, their use and method of preparation |
| 03/19/2008 | CN101146797A 4-2-(cycloalkylamino)pyrimidin-4-YL!- (phenyl)- imidazolin-2-one derivatives as p38 map-kinase inhibitors for the treatment of inflammatory diseases |